CAMP4 THERAPEUTICS CORPORATION
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.9% | -20.9% | +130.8% | +46.0% | -19.4% | -0.7% | +28.6% | +71.1% | -1.2% | +2.2% | -36.6% | -30.2% | +14.0% | +2.0% | +21.3% | +30.2% | +30.6% | +6.2% | +12.0% | +25.1% | +4.2% | -0.6% | +0.6% | -15.7% | -4.1% | -0.3% | -99.9% | +86.3% | +436.5% | |
| – | +0.3% | -28.3% | +150.9% | +59.1% | -17.4% | +2.2% | +39.5% | +61.0% | -7.8% | +5.0% | -29.2% | -50.8% | +48.9% | -5.5% | +14.1% | +27.9% | +26.1% | +4.6% | +8.9% | +16.9% | +3.5% | +0.5% | +3.1% | -16.4% | -6.6% | +6.9% | -35.9% | – | – | |
| – | -15.2% | -3.6% | +95.7% | +16.4% | -25.6% | -10.3% | -14.0% | +134.2% | +27.5% | -6.3% | -62.6% | +106.1% | -41.3% | +32.0% | +42.2% | +35.4% | +40.5% | +9.3% | +17.8% | +39.2% | +5.3% | -2.1% | -3.0% | -14.6% | -0.4% | -10.6% | -99.7% | +86.3% | +185.1% | |
| – | -22.4% | +6.7% | +8.6% | +33.8% | +8.7% | -21.1% | -10.3% | +55.1% | +9.5% | +64.8% | +4.6% | -17.9% | -15.2% | +1.7% | +1.8% | +26.2% | +47.3% | -5.7% | -0.3% | +11.1% | +17.1% | +7.4% | +6.4% | -12.3% | +10.2% | -13.6% | +65.3% | -4.4% | -1.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -12.9% | -15.8% | +24.0% | +10.7% | +18.6% | +8.1% | +60.9% | +123.0% | -6.8% | -40.4% | +85.6% | -14.9% | +6.6% | -1.0% | -77.6% | +28.5% | +16.3% | |
| – | +12.7% | -9.6% | +15.5% | -5.2% | 0.0% | -30.1% | -5.2% | +138.5% | +2.5% | +150.6% | +66.4% | -67.8% | -15.6% | -2.3% | +9.6% | +18.1% | +50.5% | +1.4% | +19.9% | +89.7% | +0.7% | -16.0% | +33.2% | -21.3% | +7.1% | -0.8% | -60.9% | +2.9% | +0.3% | |
| – | -642.9% | – | – | +13.5% | -40.7% | +56.1% | -27.1% | +118.1% | +83.1% | -221.3% | – | – | – | – | – | +116.8% | +14.8% | +36.0% | +12.6% | -95.2% | +493.2% | +147.6% | -185.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -13.8% | +53.7% | -12.7% | -61.4% | -25.1% | -80.3% | +10,448.6% | +30.3% | +3.9% | +62.7% | +20.1% | -71.0% | -10.8% | +20.6% | -25.5% | – | – | |
| – | -520.0% | – | – | – | -48.4% | +91.2% | -28.2% | +125.2% | +89.0% | -216.3% | – | – | – | – | – | +192.6% | +15.9% | +38.5% | -9.9% | -131.2% | – | -16.9% | -344.5% | – | – | – | – | – | – | |
| – | -475.0% | – | – | – | -54.8% | +116.9% | -99.1% | +18,561.5% | +103.4% | -71.8% | -853.0% | – | -136.4% | – | – | -47,932.8% | – | +35.8% | -44.9% | -124.0% | – | -112.5% | – | -97.3% | +93.8% | +5.9% | -145.6% | – | – | |
| – | -550.0% | – | – | – | -14.3% | +15.6% | +10.7% | +41.3% | +80.3% | -314.2% | – | – | – | – | – | +755.2% | -73.6% | +39.9% | +2.6% | -142.2% | – | +10.7% | -528.2% | – | – | – | – | – | – | |
| – | -131.8% | – | +10,055.5% | -12.6% | -40.0% | +13.5% | -20.4% | +91.7% | +56.7% | -29.2% | -191.3% | – | -180.6% | – | +863.4% | +90.5% | +41.1% | +30.1% | +11.5% | -35.4% | +26.9% | +50.1% | -67.7% | -44.4% | -131.2% | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.